| Date | Project | Version |
|---|---|---|
| 10 Feb | prolaio-ui | 0.6.0 |
| 3 Mar | prolaio-web | v1.8.0_carelab |
| 9 Mar | prolaio-web | v1.8.1_carelab |
| 7 Apr | prolaio-web | v1.8.2_carelab |
| 16 Apr | clinical-trial-reporting-tool | v1.0.0 |
Sprint goal hit rate was 88% (7 of 8 goals). Every sprint delivered some work, meeting the team's "value every sprint" goal. Bug count of 4 continued the low single-digit pattern seen across PI 5 to PI 7. Merged MR throughput grew from 105 to 137. Commitment was 95% of measured capacity, the closest commitment-to-capacity ratio the team has set in the period.
Completion against commitment dropped from 88.6% in PI 8 to 59.9% in PI 9. This is the largest single-PI completion drop the team has recorded.
Delivery against capacity was 67% (velocity 118 against capacity 175.2), after four PIs where the team delivered close to or above capacity.
Creep ratio rose from 10.5% to 26.9%, crossing the 20% ceiling for the first time in the trend window.
Production deploys dropped from 5 to 3 on an active-period basis (0.057/d → 0.038/d). Staging deploys dropped from 40 to 33 (0.571/d → 0.418/d), crossing back below the 0.5/d threshold.